Auditor: Del. Prescription Program Overspent By $24.5-M

Delaware has been overpaying its pharmacy benefits manager for state employees’ prescription drug coverage over a three-year period. The overpayment amounts to $24.5-million taxpayer dollars, according to a special report from State Auditor Kathy McGuiness. 鈥淔or fiscal years 2018 through 2020, the State of Delaware spent hundreds of millions of dollars on prescription drugs for…

Read More